HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1

AIDS

Volumn 21, Issue 10, 2007, Pages 1263-1272

  Grivel, Jean Charles ^a   Elliott, Julie ^b   Lisco, Andrea ^a   Biancotto, Angèlique ^a   Condack, Cristian ^a   Shattock, Robin J ^c   McGowan, Ian ^b   Margolis, Leonid ^a,d   Anton, Peter ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Co receptor; Gut associated lymphoid tissue; HIV 1; Mucosa; Tonsil

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; CD4+ T LYMPHOCYTE; COLON; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VIVO STUDY; INFECTION SENSITIVITY; INTESTINE LYMPHATIC TISSUE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; RECTUM MUCOSA; T LYMPHOCYTE SUBPOPULATION; TONSIL; VIRUS PATHOGENESIS;

COLON, SIGMOID; CYTOKINES; CYTOPATHOGENIC EFFECT, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOID TISSUE; PHARYNGEAL DISEASES; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECTAL DISEASES; RECTUM; RNA, VIRAL; SIGMOID DISEASES; T-LYMPHOCYTE SUBSETS; TONSIL; VIRUS REPLICATION;

EID: 34250009590     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3281864667     Document Type: Article

References (36)

1. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993; 262:1011- 1018.
2. Pantaleo G, Graziosi C, Demarest JF, Cohen OJ, Vaccarezza M, Gantt K, et al. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol Rev 1994; 140:105-130.
3. Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, Goudsmit J. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology 1991; 180:583-590.
4. Jung A, Maier R, Vartanian JP, Bocharov G, Jung V, Fischer U, et al. Recombination: multiply infected spleen cells in HIV patients. Nature 2002; 418:144.
5. Falk S, Stutte HJ. The spleen in HIV infection - morphological evidence of HIV-associated macrophage dysfunction. Res Virol 1990; 141:161-169.
6. Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, Melroe H, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996; 274:985-989.
7. Frankel SS, Tenner-Racz K, Racz P, Wenig BM, Hansen CH, Heffner D, et al. Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am J Pathol 1997; 151:89-96.
8. Kaminski B, Janicki K, Wiech AD. The case of a great pharyngeal tonsil hypertrophy in a twenty-one-year-old patient infected with HIV virus [in Polish]. Otolaryngol Pol 2004; 58:977-979.
9. Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, Knight HL, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998; 280:427-431.
10. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-759.
11. Veazey RS, Lackner AA. HIV swiftly guts the immune system. Nat Med 2005; 11:469-470.
12. Chase A, Zhou Y, Siliciano RF. HIV-1-induced depletion of CD4+ T cells in the gut: mechanism and therapeutic implications. Trends Pharmacol Sci 2006; 27:4-7.
13. Olsson J, Poles M, Spetz AL, Elliott J, Hultin L, Giorgi J, et al. Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J Infect Dis 2000; 182:1625-1635.
14. Delwart EL, Mullins JI, Gupta P, Learn GH Jr, Holodniy M, Katzenstein D, et al. Human immunodeficiency virus type 1 populations in blood and semen. J Virol 1998; 72:617-623.
15. Pillai SK, Good B, Pond SK, Wong JK, Strain MC, Richman DD, Smith DM. Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J Virol 2005; 79:1734-1742.
16. Fletcher PS, Elliott J, Grivel JC, Margolis L, Anton P, McGowan I, Shattock RJ. Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides. AIDS 2006; 20:1237-1245.
17. Glushakova S, Baibakov B, Margolis LB, Zimmerberg J. Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat Med 1995; 1:1320-1322.
18. Glushakova S, Baibakov B, Zimmerberg J, Margolis L. Experimental HIV infection of human lymphoid tissue: Correlation of CD4+ T cell depletion and virus syncytium-inducing/ non-syncytium-inducing phenotype in histoculture inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res Retroviruses 1997; 13:461-471.
19. Shacklett BL, Yang O, Hausner MA, Elliott J, Hultin L, Price C, et al. Optimization of methods to assess human mucosal T-cell responses to HIV infection. J Immunol Methods 2003; 279:17-31.
20. Grivel JC, Biancotto A, Ito Y, Lima RG, Margolis LB. Bystander CD4+T lymphocytes survive in HIV-infected human lymphoid tissue. AIDS Res Hum Retroviruses 2003; 19:211-216.
21. Grivel JC, Margolis LB. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat Med 1999; 5:344-346.
22. Ito Y, Grivel JC, Margolis L. Real-time PCR assay of individual human immunodeficiency virus type 1 variants in coinfected human lymphoid tissues. J Clin Microbiol 2003; 41:2126-2131.
23. Ito Y, Grivel JC, Chen S, Kiselyeva Y, Reichelderfer P, Margolis L. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines. J Infect Dis 2004; 189:506-514.
24. Grivel JC, Santoro F, Chen S, Faga G, Malnati MS, Ito Y, et al. Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J Virol 2003; 77:8280-8289.
25. Anton PA, Elliott J, Poles MA, McGowan IM, Matud J, Hultin LE, et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS 2000; 14:1761-1765.
26. Poles MA, Elliott J, Taing P, Anton PA, Chen IS. A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. J Virol 2001; 75:8390-8399.
27. Margolis L, Shattock R. Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? Nat Rev Microbiol 2006; 4:312-317.
28. Pantaleo G, Graziosi C, Fauci AS. The role of lymphoid organs in the pathogenesis of HIV infection. Semin Immunol 1993; 5:157-163.
29. Abner SR, Guenthner PC, Guarner J, Hancock KA, Cummins JE Jr, Fink A, et al. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. J Infect Dis 2005; 192:1545-1556.
30. Karlsson I, Grivel JC, Chen SS, Karlsson A, Albert J, Fenyo EM, Margolis LB. Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue. J Virol 2005; 79:11151-11160.
31. Levy JA. The search for the CD8+ cell anti-HIV factor (CAF). Trends Immunol 2003; 24:628-632.
32. Mackewicz CE, Blackbourn DJ, Levy JA. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci U S A 1995; 92:2308-2312.
33. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci U S A 1997; 94:1925-1930.
34. Penn ML, Grivel JC, Schramm B, Goldsmith MA, Margolis L. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV- 1-infected human lymphoid tissue. Proc Natl Acad Sci U S A 1999; 96:663-668.
35. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells [see Comments]. Science 1995; 270:1811-1815.
36. Mullins JI, Jensen MA. Evolutionary dynamics of HIV-1 and the control of AIDS. Curr Top Microbiol Immunol 2006; 299:171-192.